Pretax income is the income that a company earns before paying income taxes. Vera Therapeutics's pretax income for the
three
months ended in Dec. 2024 was $-43.42 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was $-152.15 Mil.
Vera Therapeutics's pretax margin was %.
Vera Therapeutics Pre-Tax Income Historical Data
The historical data trend for Vera Therapeutics's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Vera Therapeutics's Pre-Tax Income
For the Biotechnology subindustry, Vera Therapeutics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vera Therapeutics's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Vera Therapeutics's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Vera Therapeutics's Pre-Tax Income falls into.
Vera Therapeutics Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Vera Therapeutics's Pretax Income for the fiscal year that ended in Dec. 2024 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-152.15 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vera Therapeutics (NAS:VERA) Pre-Tax Income Explanation
Vera Therapeutics's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vera Therapeutics Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Vera Therapeutics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VERA has been successfully added to your 